Literature DB >> 11587480

Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.

C L Cummins1, L M Mangravite, L Z Benet.   

Abstract

PURPOSE: To examine the changes in expression levels of CYP3A4 and efflux transporters in CYP3A4-transfected Caco-2 (colon carcinoma) cells in the presence of the inducers sodium butyrate (NaB) and 12-O-tetradecanoylphorbol-13-acetate (TPA). To characterize the transport of [3H]-digoxin and the metabolism of midazolam in the cells under different inducing conditions.
METHODS: CYP3A4-Caco-2 cells were seeded onto cell culture inserts and were grown for 13-14 days. Transport and metabolism studies were performed on cells induced with NaB and/or TPA for 24 h. The expression and localization of P-gp, MRP1, MRP2, and CYP3A4 were examined by Western blot and confocal microscopy.
RESULTS: In the presence of both inducers, CYP3A4 protein levels were increased 40-fold over uninduced cells, MRP2 expression was decreased by 90%, and P-gp and MRP1 expression were unchanged. Midazolam 1-OH formation exhibited a rank order correlation with increased CYP3A4 protein, whereas [3H]-digoxin transport (a measure of P-gp activity) was unchanged with induction. P-gp and MRP2 were found on the apical membrane, whereas MRP1 was found perinuclear within the cell. CYP3A4 displayed a punctate pattern of expression consistent with endoplasmic reticulum localization and exhibited preferential polarization towards the apical side of the cell.
CONCLUSIONS: The present study characterized CYP3A4-Caco-2 cell monolayers when induced for 24 h in the presence of both NaB and TPA. These conditions provide intact cells with significant CYP3A4 and P-gp expression suitable for the concurrent study of transport and metabolism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587480     DOI: 10.1023/a:1010914624111

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels.

Authors:  P Anderle; E Niederer; W Rubas; C Hilgendorf; H Spahn-Langguth; H Wunderli-Allenspach; H P Merkle; P Langguth
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

2.  In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth.

Authors:  S Yee
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

3.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

4.  Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase.

Authors:  M Hu; Y Li; C M Davitt; S M Huang; K Thummel; B W Penman; C L Crespi
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

5.  Expression and immunolocalization of multidrug resistance protein 2 in rabbit small intestine.

Authors:  R A Van Aubel; A Hartog; R J Bindels; C H Van Os; F G Russel
Journal:  Eur J Pharmacol       Date:  2000-07-21       Impact factor: 4.432

6.  Influence of P-glycoprotein on the transport and metabolism of indinavir in Caco-2 cells expressing cytochrome P-450 3A4.

Authors:  J H Hochman; M Chiba; J Nishime; M Yamazaki; J H Lin
Journal:  J Pharmacol Exp Ther       Date:  2000-01       Impact factor: 4.030

7.  Tissue distribution of the multidrug resistance protein.

Authors:  M J Flens; G J Zaman; P van der Valk; M A Izquierdo; A B Schroeijers; G L Scheffer; P van der Groep; M de Haas; C J Meijer; R J Scheper
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

8.  Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.

Authors:  V D Makhey; A Guo; D A Norris; P Hu; J Yan; P J Sinko
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

9.  Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.

Authors:  M J Flens; M A Izquierdo; G L Scheffer; J M Fritz; C J Meijer; R J Scheper; G J Zaman
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

10.  Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers.

Authors:  K I Hosoya; K J Kim; V H Lee
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

View more
  17 in total

1.  Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.

Authors:  Kazutoshi Horie; Fuxing Tang; Ronald T Borchardt
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

Review 2.  Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.

Authors:  Chi-Yuan Wu; Leslie Z Benet
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

3.  Mechanistic study of the cellular interplay of transport and metabolism using the synthetic modeling method.

Authors:  Yu Liu; C Anthony Hunt
Journal:  Pharm Res       Date:  2006-01-31       Impact factor: 4.200

4.  Dedication to professor Leslie Z. Benet: 50 years of scientific excellence and still going strong!

Authors:  David E Smith; Malcolm Rowland; Kathleen M Giacomini; Gordon L Amidon
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

Review 5.  Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport.

Authors:  Kousei Ito; Hiroshi Suzuki; Toshiharu Horie; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

6.  Hepatic Uptake Mechanism of Ophiopogonin D Mediated by Organic Anion Transporting Polypeptides.

Authors:  Wen Zhang; Xiaomin Xiong; Lin Chen; Mingyi Liu; Yuqing Xiong; Hong Zhang; Shibo Huang; Chunhua Xia
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-08       Impact factor: 2.441

Review 7.  BDDCS, the Rule of 5 and drugability.

Authors:  Leslie Z Benet; Chelsea M Hosey; Oleg Ursu; Tudor I Oprea
Journal:  Adv Drug Deliv Rev       Date:  2016-05-13       Impact factor: 15.470

Review 8.  The drug transporter-metabolism alliance: uncovering and defining the interplay.

Authors:  Leslie Z Benet
Journal:  Mol Pharm       Date:  2009 Nov-Dec       Impact factor: 4.939

9.  Gene expression profiles of ABC transporters and cytochrome P450 3A in Caco-2 and human colorectal cancer cell lines.

Authors:  Tsutomu Nakumura; Toshiyuki Sakaeda; Nobuko Ohmoto; Yuka Moriya; Chiho Komoto; Toshiro Shirakawa; Akinobu Gotoh; Masafumi Matsuo; Katsuhiko Okmura
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

10.  Human Primary Cell-Based Organotypic Microtissues for Modeling Small Intestinal Drug Absorption.

Authors:  Seyoum Ayehunie; Tim Landry; Zachary Stevens; Alex Armento; Patrick Hayden; Mitchell Klausner
Journal:  Pharm Res       Date:  2018-02-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.